• Investing Ideas
  • /
  • U.S. Pharmaceuticals & Biotech High Growth Potential Companies
166 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

RCEL

AVITA Medical
US$16.43-4.1%22.8%US$423.3mUS$26.49PS8.4xE64.0%n/a

TGTX

TG Therapeutics
US$15.22-7.0%4.2%US$2.2bUS$29.75PE173.9xE49.9%n/a

ZVRA

Zevra Therapeutics
US$6.00-2.1%21.2%US$248.9mUS$18.25PS15xE59.5%n/a

ALNY

Alnylam Pharmaceuticals
US$149.270.1%-20.4%US$18.8bUS$220.76PS10.3xE60.8%n/a

GTHX

G1 Therapeutics
US$3.11-10.6%5.8%US$162.3mUS$8.50PS2xE55.1%n/a

AXSM

Axsome Therapeutics
US$75.546.5%19.5%US$3.6bUS$120.53PS13.2xE60.3%n/a

SGEN

Seagen
US$228.744.5%76.5%US$43.2bUS$228.91PS18.8xE71.8%n/a

IMGN

ImmunoGen
US$31.236.6%617.9%US$8.4bUS$28.95PS29.1xE45.8%n/a

ITCI

Intra-Cellular Therapies
US$64.78-1.0%40.9%US$6.3bUS$83.10PS13.5xE56.6%n/a

ARDX

Ardelyx
US$8.10-4.6%108.8%US$1.9bUS$13.31PS15.1xE60.6%n/a

FOLD

Amicus Therapeutics
US$11.48-5.4%-0.5%US$3.4bUS$19.22PS8.5xE55.0%n/a

MIRM

Mirum Pharmaceuticals
US$26.77-0.6%13.4%US$1.3bUS$49.10PS6.8xE63.4%n/a

APLS

Apellis Pharmaceuticals
US$56.74-6.5%-10.0%US$6.8bUS$82.69PS17.3xE60.0%n/a

AVDL

Avadel Pharmaceuticals
US$15.92-0.5%94.7%US$1.4bUS$22.90PS51.6xE56.7%n/a

ISEE

IVERIC bio
US$39.950.9%236.3%US$5.5bUS$40.00PB11.6xE59.0%n/a

MGTX

MeiraGTx Holdings
US$6.35-0.3%17.4%US$407.8mUS$21.60PS29.1xE52.8%n/a

HALO

Halozyme Therapeutics
US$40.86-0.8%17.3%US$5.2bUS$50.70PE18.4xE20.8%n/a

OLK

Olink Holding
US$23.930.7%9.8%US$3.0bUS$26.00PS18.7xE51.4%n/a

ASND

Ascendis Pharma
US$148.700.4%35.4%US$8.4bUS$179.31PS29xE65.1%n/a

EVOK

Evoke Pharma
US$0.62-5.3%-78.7%US$5.3mUS$7.00PS1xE79.9%n/a

ABEO

Abeona Therapeutics
US$8.6310.5%275.2%US$213.8mUS$21.50PS59.9xE55.4%n/a

SPRY

ARS Pharmaceuticals
US$9.1610.5%9.1%US$879.3mUS$18.50PS29311.2xE51.3%n/a

AGRX

Agile Therapeutics
US$0.54-24.4%-94.8%US$1.6mUS$5.00PE-0.1xE57.9%n/a

ENSC

Ensysce Biosciences
US$0.793.5%-88.2%US$5.8mUS$13.60PS2.6xE62.6%n/a
Page 1 of 7
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.